Skip to content

Splanchnic aspartate metabolism in preterm infants

Splanchnic aspartate metabolism in preterm infants - Splanchnic aspartate metabolism in preterm infants

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30148
Enrollment
10
Registered
2007-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Up take of nutrients in the intestine/ Use of nutrients by the intestineBi

Interventions

The Ethical Committee Rotterdam and the CCMO decided that this study should be examined by the CCMO as a non-therapeutical intervention study because the neonate receives formula instead of mother m
the metabolism of nutritional parts is the purpose of this study.

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Birth weight between 750 and 1500 grams, admitted to the NICU, at least 1 day on full enteral feeding, clinically stable. Intravenous catheter in situ.

Exclusion criteria

Exclusion criteria: No intravenous catheter in situ, metabolic/congenital disease, abnormal liver or kidney function, clinically instabel, sepsis or NEC. On CPAP or infant flow.

Design outcomes

Primary

MeasureTime frame
Plasma and expired air enrichment of IV and IG adminstered labelled aspartate. For this purpose we will use two different stable isotopes of aspartate.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)